Jessica Tao

Assistant Professor

If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Jessica Tao is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles
TOR Serine-Threonine Kinases Medicine & Life Sciences
Phosphatidylinositol 3-Kinases Medicine & Life Sciences
Phosphatidylinositol 3-Kinase Medicine & Life Sciences
Neuregulin-1 Medicine & Life Sciences
Proto-Oncogene Proteins c-akt Medicine & Life Sciences
Tumor Cell Line Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
ErbB-3 Receptor Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2013 2019

First-in-human phase i study of the activin a inhibitor, STM 434, in patients with granulosa cell ovarian cancer and other advanced solid tumors

Tao, J., Cangemi, N. A., Makker, V., Cadoo, K. A., Liu, J. F., Rasco, D. W., Navarro, W. H., Haqq, C. M. & Hyman, D. M., Sep 15 2019, In : Clinical Cancer Research. 25, 18, p. 5458-5465 8 p.

Research output: Contribution to journalArticle

Granulosa Cell Tumor
Ovarian Neoplasms
Growth Differentiation Factor 2

RAF inhibitor PLX8394 selectively disrupts BRAF dimers and RAS-independent BRAF-mutant-driven signaling

Yao, Z., Gao, Y., Su, W., Yaeger, R., Tao, J., Na, N., Zhang, Y., Zhang, C., Rymar, A., Tao, A., Timaul, N. M., Mcgriskin, R., Outmezguine, N. A., Zhao, H. Y., Chang, Q., Qeriqi, B., Barbacid, M., de Stanchina, E., Hyman, D. M., Bollag, G. & 1 others, Rosen, N., Feb 1 2019, In : Nature medicine. 25, 2, p. 284-291 8 p.

Research output: Contribution to journalLetter

Drug Resistance
Protein Isoforms

Basket Studies: Redefining Clinical Trials in the Era of Genome-Driven Oncology

Tao, J., Schram, A. M. & Hyman, D. M., Jan 29 2018, In : Annual review of medicine. 69, p. 319-331 13 p.

Research output: Contribution to journalArticle

Clinical Trials

Learning all that we can from MyPathway

Tao, J., Schram, A. M., Harding, J. J., Drilon, A. & Hyman, D. M., Aug 10 2018, In : Journal of Clinical Oncology. 36, 23, p. 2450-2451 2 p.

Research output: Contribution to journalLetter


PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor-positive breast cancer

Bosch, A., Li, Z., Bergamaschi, A., Ellis, H., Toska, E., Prat, A., Tao, J., Spratt, D. E., Viola-Villegas, N. T., Castel, P., Minuesa, G., Morse, N., Rodón, J., Ibrahim, Y., Cortes, J., Perez-Garcia, J., Galvan, P., Grueso, J., Guzman, M., Katzenellenbogen, J. A. & 8 others, Kharas, M., Lewis, J. S., Dickler, M., Serra, V., Rosen, N., Chandarlapaty, S., Scaltriti, M. & Baselga, J., Apr 15 2015, In : Science translational medicine. 7, 283, 283ra51.

Research output: Contribution to journalArticle